
Standardizing the Amyloid Frontier: Inside FDA Clearance of MICSI-PET
Dr. Dereck Mush, MD, MBASiemens Healthineers is a medical technology company that makes imaging systems, laboratory diagnostics, and radiation therapy equipment.
Siemens Healthineers serves hospitals and laboratories through its Imaging, Diagnostics and Precision Therapy businesses. The company is listed on XETRA as SHL. For the fourth quarter of fiscal 2026 it reported revenue of 6.78 billion euros, up 7.3 percent, an adjusted EBIT margin of 15.9 percent and free cash flow of 703 million euros, with comparable revenue growth of 4.0 percent for the full fiscal year. Bernd Montag is Chief Executive Officer.
Leadership as of 14 November 2026.
Chief Executive Officer
How Siemens Healthineers got here, step by step.
November 2026
Siemens Healthineers reported fourth quarter fiscal 2026 revenue of 6.78 billion euros, up 7.3 percent, and full fiscal year comparable revenue growth of 4.0 percent.
19 November 2026
Announced FDA clearance of syngo.CT Coronary Cockpit.
Reported November 2026

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The 2026 Cardiac MRI AI Landscape: From Acquisition to Automated Reporting
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAMentions Siemens Healthineers
Related companies
Your daily HealthTech Signal
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: